Results 51 to 60 of about 1,464 (122)

Electron Tomography Imaging of Surface Glycoproteins on Human Parainfluenza Virus 3: Association of Receptor Binding and Fusion Proteins before Receptor Engagement

mBio, 2015
In order to deliver their genetic material to host cells during infection, enveloped viruses use specialized proteins on their surfaces that bind cellular receptors and induce fusion of the viral and host membranes.
Long Gui, Eric M. Jurgens, Jamie L. Ebner, Matteo Porotto, Anne Moscona, Kelly K. Lee   +5 more
doaj   +1 more source

Recent increase in the detection of human parainfluenza virus during the coronavirus disease-2019 pandemic in the Republic of Korea

Virology Journal, 2022
Background Since the onset of the coronavirus disease-2019 (COVID-19) pandemic, the prevalence of respiratory infectious diseases, particularly, the flu epidemic, has considerably decreased.
Heui Man Kim, Jee Eun Rhee, Nam-Joo Lee, Sang Hee Woo, Ae Kyung Park, Jaehee Lee, Cheon Kwon Yoo, Eun-Jin Kim   +7 more
doaj   +1 more source

Clinical and epidemiological characteristics of human parainfluenza virus infections of children in southern Taiwan

Journal of Microbiology, Immunology and Infection, 2018
Background: Human parainfluenza viruses (HPIV) 1–4 had been analyzed as being one of the most frequent causes of hospitalizations for young children with respiratory tract illnesses.
Kai-Wen Wu, Shih-Min Wang, Ching-Fen Shen, Tzong-Shiann Ho, Jen-Ren Wang, Ching-Chuan Liu   +5 more
doaj   +1 more source

Adaptation of Human Parainfluenza Virus to Airway Epithelium Reveals Fusion Properties Required for Growth in Host Tissue

mBio, 2012
Paramyxoviruses, a family of RNA enveloped viruses that includes human parainfluenza virus type 3 (HPIV3), cause the majority of childhood croup, bronchiolitis, and pneumonia worldwide.
Samantha G. Palmer, Matteo Porotto, Laura M. Palermo, Luis F. Cunha, Olga Greengard, Anne Moscona   +5 more
doaj   +1 more source

Development of oligomannose-coated liposome-based nasal vaccine against human parainfluenza virus type 3

Frontiers in Microbiology, 2013
Human parainfluenza viruses (HPIVs) are the etiologic agents of lower respiratory infections and pneumonia in infants, young children and immunocompromised hosts.
Kyosuke eSenchi, Satoko eMatsunaga, Hideki eHasegawa, Hirokazu eKimura, Akihide eRyo   +4 more
doaj   +1 more source

Human parainfluenza virus fusion complex glycoproteins imaged in action on authentic viral surfaces.

PLoS Pathogens, 2020
Infection by human parainfluenza viruses (HPIVs) causes widespread lower respiratory diseases, including croup, bronchiolitis, and pneumonia, and there are no vaccines or effective treatments for these viruses.
Tara C Marcink, Tong Wang, Amedee des Georges, Matteo Porotto, Anne Moscona   +4 more
doaj   +1 more source

Impact of the COVID-19 pandemic on the prevalence of respiratory viral pathogens in patients with acute respiratory infection in Shanghai, China

Frontiers in Public Health
ObjectiveThis study aimed to evaluate the impact of nonpharmaceutical interventions (NPIs) taken to combat COVID-19 on the prevalence of respiratory viruses (RVs) of acute respiratory infections (ARIs) in Shanghai.MethodsSamples from ARI patients were ...
Lifeng Pan, Lifeng Pan, Yang Yuan, Qiqi Cui, Qiqi Cui, Xuechun Zhang, Yujia Huo, Qing Liu, Wenwei Zou, Bing Zhao, Bing Zhao, Lipeng Hao, Lipeng Hao   +12 more
doaj   +1 more source

Additional file 9 of Peptides targeting RAB11A–FIP2 complex inhibit HPIV3, RSV, and IAV replication as broad-spectrum antivirals

Supplementary Material 9.
Jiang, Yanliang, Zhao, Yongliang, Deng, Jie, Wu, Xiaoyan, Li, Jian, Guo, Dong, Xu, Ke, Qin, Yali, Chen, Mingzhou   +8 more
openaire   +1 more source

Host factors in parainfluenza virus replication: from entry to innate immunity evasion. [PDF]

Front Immunol
Lin X, Zhu Y, Jing L, Xiao X, Lei X, Xie Z.   +5 more
europepmc   +1 more source

Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus models. [PDF]

Sci Adv
Lieber CM, Wolf JD, Govindarajan M, Yoon JJ, Sticher ZM, Ruckel CE, Leach AI, Harrison LA, Vyshenska D, Cruz AA, Andrews MK, Krueger RE, Cox RM, Painter GR, Greninger AL, Natchus MG, Plemper RK.   +16 more
europepmc   +1 more source